Development of Gemcitabine-Modified miRNA Mimics as Cancer Therapeutics for Pancreatic Ductal Adenocarcinoma.
John G YuenGa-Ram HwangAndrew FeslerErick IntriagoAmartya PalAnushka OjhaJingfang JuPublished in: bioRxiv : the preprint server for biology (2023)
have developed a potent therapeutic strategy for patients with pancreatic cancer by modifying microRNAs with gemcitabine.